Dorzolamide (trade name Trusopt) is a carbonic anhydrase inhibitor. It is an anti-glaucoma agent and topically applied in the form of eye drops. This drug, developed by Merck, was the first drug in human therapy (market introduction 1995) which resulted from structure-based drug design. Dorzolamide hydrochloride is used to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension. The combination of dorzolamide with timolol is marketed under the trade name Cosopt.
MedKoo Cat#: 315352
Name: Dorzolamide hydrochloride
CAS#: 130693-82-2 (HCl)
Chemical Formula: C10H17ClN2O4S3
Exact Mass: 0.0000
Molecular Weight: 360.90
Elemental Analysis: C, 33.28; H, 4.75; Cl, 9.82; N, 7.76; O, 17.73; S, 26.65
The following data is based on the product molecular weight 360.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
-β-Tocopherol3513.jpg "(±)-β-Tocopherol")